Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Indivior Pharmaceuticals' Change in Acquisitions & Divestments fell 9347.83% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 6475.41%. This contributed to the annual value of $117.0 million for FY2024, which is 930.23% down from last year.
  • According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Change in Acquisitions & Divestments is $3.0 million, which was down 9347.83% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $46.0 million in Q3 2024 and a low of $3.0 million during Q3 2025
  • In the last 4 years, Indivior Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $28.0 million in 2023 and averaged $21.3 million.
  • Per our database at Business Quant, Indivior Pharmaceuticals' Change in Acquisitions & Divestments surged by 52000.0% in 2023 and then tumbled by 9347.83% in 2025.
  • Indivior Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $12.0 million in 2022, then surged by 183.33% to $34.0 million in 2023, then dropped by 14.71% to $29.0 million in 2024, then tumbled by 89.66% to $3.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $3.0 million in Q3 2025, compared to $5.0 million in Q2 2025 and $6.0 million in Q1 2025.